PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma
Titel:
PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma
Auteur:
Pour, Ludek Micheva, Ilina Usenko, Ganna Mikala, Gabor Masszi, Tamas Simeonova, Kameliya Thuresson, Marcus Huledal, Gunilla Norin, Stefan Bakker, Nicolaas A. Minarik, Jiri